COVID-19 Vaccine Take-up Rate, Safety and Tolerability in Patients with Epilepsy
Objective:Although vaccines are considered safe for most people, patients with some chronic diseases have been very hesitant to get vaccinated, especially at the initial stages of vaccination. We conducted a survey among patients with epilepsy (PWE) who are currently experiencing hesitations, aiming...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2023-06-01
|
| Series: | Archives of Epilepsy |
| Subjects: | |
| Online Access: |
http://archepilepsy.org/archives/archive-detail/article-preview/covd-19-vaccine-take-up-rate-safety-and-tolerabili/60572
|
| _version_ | 1797767418296139776 |
|---|---|
| author | Firdevs Ezgi Uçan Tokuç Fatma Genç Yasemin Biçer Gömceli |
| author_facet | Firdevs Ezgi Uçan Tokuç Fatma Genç Yasemin Biçer Gömceli |
| author_sort | Firdevs Ezgi Uçan Tokuç |
| collection | DOAJ |
| description | Objective:Although vaccines are considered safe for most people, patients with some chronic diseases have been very hesitant to get vaccinated, especially at the initial stages of vaccination. We conducted a survey among patients with epilepsy (PWE) who are currently experiencing hesitations, aiming to investigate the vaccination rates against Coronavirus disease-2019 (COVID-19) and the side effects emerged in vaccinated patients.Methods:Two hundred nineteen PWE were questioned during a routine outpatient follow-up through previously prepared questionnaires that contained questions about patients’ demographic features, information about the vaccination status, and its adverse effects.Results:We included 219 PWE in the study of which 112 (51.1%) were female and 107 (48.8%) were male. One hundred eighty patients (82.1%) had been vaccinated at least once, 75% of the patients preferred two doses of BNT162b2 mRNA COVID-19 vaccine, 9.4% of the patients preferred two doses of Sinovac’s inactivated vaccine, 6.1% of the patients preferred three doses of Sinovac, and 9.4% of the patients preferred Sinovac and BNT162b2 vaccines. Seventy-seven (42.7%) patients reported that they experienced side effects after vaccination whereas ten patients (5.5%) reported worsening of their seizures after vaccination; one person stated that she/he was hospitalized in the intensive care unit due to status epilepticus.Conclusion:Generally, the tolerance of COVID-19 vaccines has progressed with mild side effects in most cases, which is consistent with previous studies in the general population, similarly no serious and previously unreported side effects were found in our study. Our study showed that COVID-19 vaccines are well-tolerated and safe for seizures in PWE. |
| first_indexed | 2024-03-12T20:38:29Z |
| format | Article |
| id | doaj.art-ba04da86037c4aa6a0d6c699519dde27 |
| institution | Directory Open Access Journal |
| issn | 2792-0550 |
| language | English |
| last_indexed | 2024-03-12T20:38:29Z |
| publishDate | 2023-06-01 |
| publisher | Galenos Yayinevi |
| record_format | Article |
| series | Archives of Epilepsy |
| spelling | doaj.art-ba04da86037c4aa6a0d6c699519dde272023-08-01T11:14:30ZengGalenos YayineviArchives of Epilepsy2792-05502023-06-01292505510.4274/ArchEpilepsy.2023.22424713049054COVID-19 Vaccine Take-up Rate, Safety and Tolerability in Patients with EpilepsyFirdevs Ezgi Uçan Tokuç0Fatma Genç1Yasemin Biçer Gömceli2 University of Health Sciences Turkey, Antalya Training and Research Hospital, Clinic of Neurology, Antalya, Turkey University of Health Sciences Turkey, Antalya Training and Research Hospital, Clinic of Neurology, Antalya, Turkey Memorial Antalya Hospital, Clinic of Neurology, Antalya, Turkey Objective:Although vaccines are considered safe for most people, patients with some chronic diseases have been very hesitant to get vaccinated, especially at the initial stages of vaccination. We conducted a survey among patients with epilepsy (PWE) who are currently experiencing hesitations, aiming to investigate the vaccination rates against Coronavirus disease-2019 (COVID-19) and the side effects emerged in vaccinated patients.Methods:Two hundred nineteen PWE were questioned during a routine outpatient follow-up through previously prepared questionnaires that contained questions about patients’ demographic features, information about the vaccination status, and its adverse effects.Results:We included 219 PWE in the study of which 112 (51.1%) were female and 107 (48.8%) were male. One hundred eighty patients (82.1%) had been vaccinated at least once, 75% of the patients preferred two doses of BNT162b2 mRNA COVID-19 vaccine, 9.4% of the patients preferred two doses of Sinovac’s inactivated vaccine, 6.1% of the patients preferred three doses of Sinovac, and 9.4% of the patients preferred Sinovac and BNT162b2 vaccines. Seventy-seven (42.7%) patients reported that they experienced side effects after vaccination whereas ten patients (5.5%) reported worsening of their seizures after vaccination; one person stated that she/he was hospitalized in the intensive care unit due to status epilepticus.Conclusion:Generally, the tolerance of COVID-19 vaccines has progressed with mild side effects in most cases, which is consistent with previous studies in the general population, similarly no serious and previously unreported side effects were found in our study. Our study showed that COVID-19 vaccines are well-tolerated and safe for seizures in PWE. http://archepilepsy.org/archives/archive-detail/article-preview/covd-19-vaccine-take-up-rate-safety-and-tolerabili/60572 epilepsycovid-19 vaccinationpfizer biontechsinovac-coronavacside effect |
| spellingShingle | Firdevs Ezgi Uçan Tokuç Fatma Genç Yasemin Biçer Gömceli COVID-19 Vaccine Take-up Rate, Safety and Tolerability in Patients with Epilepsy Archives of Epilepsy epilepsy covid-19 vaccination pfizer biontech sinovac-coronavac side effect |
| title | COVID-19 Vaccine Take-up Rate, Safety and Tolerability in Patients with Epilepsy |
| title_full | COVID-19 Vaccine Take-up Rate, Safety and Tolerability in Patients with Epilepsy |
| title_fullStr | COVID-19 Vaccine Take-up Rate, Safety and Tolerability in Patients with Epilepsy |
| title_full_unstemmed | COVID-19 Vaccine Take-up Rate, Safety and Tolerability in Patients with Epilepsy |
| title_short | COVID-19 Vaccine Take-up Rate, Safety and Tolerability in Patients with Epilepsy |
| title_sort | covid 19 vaccine take up rate safety and tolerability in patients with epilepsy |
| topic | epilepsy covid-19 vaccination pfizer biontech sinovac-coronavac side effect |
| url |
http://archepilepsy.org/archives/archive-detail/article-preview/covd-19-vaccine-take-up-rate-safety-and-tolerabili/60572
|
| work_keys_str_mv | AT firdevsezgiucantokuc covid19vaccinetakeupratesafetyandtolerabilityinpatientswithepilepsy AT fatmagenc covid19vaccinetakeupratesafetyandtolerabilityinpatientswithepilepsy AT yaseminbicergomceli covid19vaccinetakeupratesafetyandtolerabilityinpatientswithepilepsy |